Description
BMC Remedy Mid Tier 9.1SP3 is affected by cross-site scripting (XSS). A DOM-based cross-site scripting vulnerability was discovered in a legacy utility.
No analysis available yet.
Remediation
No remediation available yet.
Tracking
Sign in to view the affected projects.
Advisories
| Source | ID | Title |
|---|---|---|
EUVD |
EUVD-2017-8835 | BMC Remedy Mid Tier 9.1SP3 is affected by cross-site scripting (XSS). A DOM-based cross-site scripting vulnerability was discovered in a legacy utility. |
References
History
No history.
Status: PUBLISHED
Assigner: mitre
Published:
Updated: 2026-07-05T00:01:26.876Z
Reserved: 2017-12-13T00:00:00.000Z
Link: CVE-2017-17678
No data.
Status : Modified
Published: 2021-05-19T14:15:07.367
Modified: 2026-06-17T01:11:28.930
Link: CVE-2017-17678
No data.
OpenCVE Enrichment
No data.
Weaknesses
-
CWE-79
Improper Neutralization of Input During Web Page Generation ('Cross-site Scripting')
EUVD